Telix Pharmaceuticals Ltd (ASX: TLX) Share Price and News
Price
Movement
52 Week Range
-
1 Year Return
(20 mins delayed)
() Chart and Price Data
Share Price
Previous Close
Volume
Day Change
Open
Monthly Average Volume
52 Week Range
-
Days Range
-
Turnover
Fundamental Company Figures
Data provided by Morningstar.
Market Cap
$1.12 billion
P/E Ratio
N/A
Dividend Yield
N/A
Shares Outstanding
281.37 million
Earnings per share
-0.175
Dividend per share
N/A
Year To Date Return
7.67%
Earnings Yield
N/A
Franking
N/A
Telix Pharmaceuticals Ltd (ASX: TLX) Latest News
Why the Telix (ASX:TLX) share price is storming 5% higher
James Mickleboro | April 14, 2021 10:11am
3 ASX shares that helped this fund manager smash the market
James Mickleboro | February 2, 2021 4:00pm
Why Ampol, Flight Centre, Syrah, & Telix shares are dropping lower
James Mickleboro | January 25, 2021 12:47pm
Why the Telix (ASX:TLX) share price is dropping lower today
James Mickleboro | January 25, 2021 10:25am
How the Telix (ASX:TLX) share price roared over 150% in a year
Gretchen Kennedy | January 6, 2021 1:10pm
The Telix (ASX:TLX) share price is on the move today. Here’s why.
Aaron Teboneras | December 9, 2020 10:38am
Telix (ASX:TLX) share price slips despite priority review status
Bernd Struben | December 7, 2020 3:59pm
Recent Stock Announcements
Price Sensitive OnlyAn announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
Show All
| Date | Heading | An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security. | Time | Pages | File Size |
|---|---|---|---|---|---|
About Telix Pharmaceuticals Ltd (ASX: TLX)
Telix Pharmaceuticals Ltd is a clinical-stage biotechnology company engaged in developing and commercializing molecularly-targeted radiation therapy to address the unmet needs in the management of prostate, renal (kidney) and glioblastoma (brain) cancer. Geographically, it operates in Australia, the United States, Belgium, and Japan.
Share Price History
Data provided by Morningstar.| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 16 Apr 2021 | $3.97 | $-0.10 | -2.46% | 641,047 | $4.08 | $4.08 | $3.92 |
| 15 Apr 2021 | $4.07 | $0.01 | 0.25% | 257,055 | $4.17 | $4.20 | $4.03 |
| 14 Apr 2021 | $4.06 | $0.02 | 0.50% | 487,088 | $4.15 | $4.25 | $4.06 |
| 13 Apr 2021 | $4.04 | $-0.03 | -0.74% | 233,761 | $4.07 | $4.17 | $4.02 |
| 12 Apr 2021 | $4.07 | $-0.18 | -4.24% | 465,510 | $4.20 | $4.25 | $4.07 |
| 09 Apr 2021 | $4.25 | $0.06 | 1.43% | 297,054 | $4.26 | $4.29 | $4.19 |
| 08 Apr 2021 | $4.19 | $0.00 | 0.00% | 697,956 | $4.21 | $4.29 | $4.14 |
| 07 Apr 2021 | $4.19 | $-0.39 | -8.52% | 1,102,031 | $4.65 | $4.74 | $4.13 |
| 06 Apr 2021 | $4.58 | $0.10 | 2.23% | 859,556 | $4.55 | $4.65 | $4.43 |
| 01 Apr 2021 | $4.48 | $0.20 | 4.67% | 616,820 | $4.39 | $4.53 | $4.35 |
| 31 Mar 2021 | $4.28 | $-0.05 | -1.15% | 690,656 | $4.46 | $4.54 | $4.27 |
| 30 Mar 2021 | $4.33 | $-0.07 | -1.59% | 312,360 | $4.41 | $4.48 | $4.33 |
| 29 Mar 2021 | $4.40 | $-0.10 | -2.22% | 204,380 | $4.55 | $4.55 | $4.37 |
| 26 Mar 2021 | $4.50 | $0.00 | 0.00% | 197,792 | $4.50 | $4.54 | $4.44 |
| 25 Mar 2021 | $4.50 | $-0.01 | -0.22% | 435,002 | $4.55 | $4.56 | $4.40 |
| 24 Mar 2021 | $4.51 | $-0.21 | -4.45% | 780,638 | $4.72 | $4.80 | $4.42 |
| 23 Mar 2021 | $4.72 | $0.19 | 4.19% | 1,573,668 | $4.50 | $4.77 | $4.50 |
| 22 Mar 2021 | $4.53 | $0.19 | 4.38% | 1,055,179 | $4.30 | $4.58 | $4.28 |
| 19 Mar 2021 | $4.34 | $-0.02 | -0.46% | 7,345,085 | $4.25 | $4.41 | $4.20 |
| 18 Mar 2021 | $4.36 | $0.15 | 3.56% | 987,554 | $4.29 | $4.43 | $4.26 |
| 17 Mar 2021 | $4.21 | $0.06 | 1.45% | 1,307,035 | $4.15 | $4.33 | $4.12 |
Director Transactions
Data provided by Morningstar.Directors & Management
Data provided by Morningstar.
Show more
Top Share Holders
Data provided by Morningstar.| Name | Shares | Capital |
|---|---|---|
| HSBC Custody Nominees (Australia) Limited | 37,477,609 | 13.37% |
| ELK River Holdings Pty Ltd | 24,675,000 | 8.80% |
| Gnosis Verwaltungsgesellschaftm B H | 24,675,000 | 8.80% |
| Grand Decade Developments Limited | 20,947,181 | 7.47% |
| J P Morgan Nominees Australia Pty Limited | 8,371,563 | 2.99% |
| UV Cap Gmbh & Co Kg | 7,775,000 | 2.77% |
| BNP Paribas Noms Pty Ltd | 6,904,087 | 2.46% |
| The Oncidium Foundation | 6,470,392 | 2.31% |
| National Nominees Limited | 6,361,306 | 2.27% |
| Citicorp Nominees Pty Limited | 6,249,988 | 2.23% |
| Scintec Diagnostics Gmbh | 4,312,151 | 1.54% |
| BNP Paribas Nominees Pty Ltd | 3,782,218 | 1.35% |
| UBS Nominees Pty Ltd | 3,029,153 | 1.08% |
| HSBC Custody Nominees (Australia) Limited A/C 2 | 2,843,462 | 1.01% |
| Jean Marc Le Doussal | 2,750,000 | 0.98% |
| Ilusa Sprl | 2,558,138 | 0.91% |
| Yelwac Pty Ltd | 2,381,804 | 0.85% |
| Man Holdings Pty Ltd | 2,238,750 | 0.80% |
| Telix Pharmaceuticals (Est) Pty Ltd | 2,115,000 | 0.75% |
| Aglub Investments Pty Ltd | 1,933,342 | 0.69% |
| Jean Francois Chatal | 1,797,795 | 0.64% |